01.002 RWE GS Aug 2022 A 10-8-22

NICE and Flatiron partner to utilise real-world oncology data in informing decisions about cancer therapy access

  • Flatiron Health are already partnered with the FDA in the US since 2016, with whom they have explored real-world outcomes and alternative study methods
  • Experts from both NICE and Flatiron Health will conduct research using Flatiron’s electronic health record (EHR)-derived database
  • “We are excited to explore how real-world evidence could be incorporated into our work in the future. Working in this way will test how additional sources of evidence could complement trial and research data in our technology appraisals, especially in helping to resolve uncertainty in the evidence.” – Pall Jonsson, Associate Director for Science Policy and Research, NICE
Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.


DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.

For more information, please visit and contact us at